2023³â ´ëÇѽÅÃéÀåÀ̽Ŀܰú¿¬±¸È¸ Ãá°è ½ÉÆ÷Áö¾ö : 2023-04-14
±³À°ÀÏÀÚ : 2023-04-14
±³À°Àå¼Ò : ¼¿ï´ëÇб³º´¿ø CMI 1Ãþ ¼¼ºÈ¯ ¿¬±¸È¦
±³À°ÁÖÁ¦ : 2023³â ´ëÇѽÅÃéÀåÀ̽Ŀܰú¿¬±¸È¸ Ãá°è ½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ´ëÇÑ¿Ü°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѽÅÃéÀåÀ̽Ŀܰú¿¬±¸È¸
´ã´çÀÚ : °íÇö¹Î
¿¬¶ôó : 02-797-1220
À̸ÞÀÏ : ksgkpt@gmail.com
±³À°Á¾·ù : ¿Ü°ú
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 200,000¿ø
ºñ°í »çÀüµî·Ï) Á¤È¸¿ø- 80,000¿ø ÁØȸ¿ø- 30,000¿ø ºñȸ¿ø- 150,000¿øÇöÀåµî·Ï) Á¤È¸¿ø- 100,000¿ø ÁØȸ¿ø- 50,000¿ø ºñȸ¿ø- 200,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 04-14 09:30~10:00 Registration ()
±âŸ 04-14 10:00~10:05 Welcome Address ÇÏÁ¾¿ø(¼¿ïÀÇ´ë)
±âŸ 04-14 10:05~10:10 Congratulatory address ´ëÇÑ¿Ü°úÇÐȸȸÀå À±µ¿¼·(¿¬¼¼ÀÇ´ë)
±âŸ 04-14 10:10~11:40 Session I. Deceased Donor Kidney Transplantation in KOREA ¹ÚÀç¹ü / ¾ÈÇüÁØ(¼º±Õ°üÀÇ´ë / °æÈñÀÇ´ë)
±³À°½Ã°£ 04-14 10:10~10:40 Current status of DDKT and Kidney Organ Allocation Policy in KOREA ÀüÈ︸(°í·ÁÀÇ´ë)
±³À°½Ã°£ 04-14 10:40~11:10 Deceased Donor KT Expanded criteria donor °í¿µ¹Î(¿ï»êÀÇ´ë)
±³À°½Ã°£ 04-14 11:10~11:40 Role of Machine perfusion Àå¿ø¹è(Á¦ÁÖÀÇ´ë)
±âŸ 04-14 11:40~13:00 Photo/Lunch ()
±âŸ 04-14 13:00~14:30 Session II. Current immunosuppression in kidney transplantation ¹Ú¼øö / Á¤Ã¶¿õ(°¡Å縯ÀÇ´ë / °í·ÁÀÇ´ë)
±³À°½Ã°£ 04-14 13:00~13:30 Induction immunosuppression in KT À̱³¿ø(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 04-14 13:30~14:00 Optimizing trough level and intrapatient variability of tacrolimus in KT ÇѾƶ÷(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04-14 14:00~14:30 Clinical usefulness of mTOR(mammalian target of rapamycin) inhibitor in KT ¼Û½Âȯ(ÀÌÈÀÇ´ë)
ÈÞ½Ä 04-14 14:30~15:00 Coffee Break ()
±âŸ 04-14 15:00~16:30 Session III. Kidney transplantation in high immunologic risk recipients Çã±ÔÇÏ / ±è¿µÈÆ(¿¬¼¼ÀÇ´ë / ¿ï»êÀÇ´ë)
±³À°½Ã°£ 04-14 15:00~15:30 Pretransplant immunological risk assessment ¹Ú±Ýº¸·¡(KODA)
±³À°½Ã°£ 04-14 15:30~16:00 Current approach to desensitization and transplant outcomes in ABO/HLA(human leukocyte antigen)-incompatible KT ±ÇÇö¿í(¿ï»êÀÇ´ë)
±³À°½Ã°£ 04-14 16:00~16:30 Challenges and limitations of KT in high immunologic risk recipients ÀÌÁÖÇÑ(¿¬¼¼ÀÇ´ë)
±âŸ 04-14 16:30~17:00 Special Session ÇÏÁ¾¿ø(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04-14 16:30~17:00 K-NSQIP(National Surgical Quality Improvement Program in Korea) KT ¹Î»óÀÏ(¼¿ïÀÇ´ë)